A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects.

Trial Profile

A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Epilepsy; Tonic-clonic epilepsy
  • Focus Pharmacodynamics
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
    • 10 Dec 2013 Results presented at the 67th Annual Meeting of the American Epilepsy Society.
    • 17 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top